Ameritas Investment Partners’s Acumen Pharmaceuticals ABOS Stock Holding History

Ameritas Investment Partners’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,110	Closed	-$4.52K	–	3198
2025 Q1	$4.52K	Hold	4,110	–	–	﹤0.01%	2994
2024 Q4	$7.07K	Hold	4,110	–	–	﹤0.01%	2986
2024 Q3	$10.2K	Hold	4,110	–	–	﹤0.01%	2911
2024 Q2	$9.95K	Buy	+4,110	New	+$13.1K	﹤0.01%	2931
2022 Q2	–	Sell	-2,205	Closed	-$9K	–	3053
2022 Q1	$9K	Buy	2,205 +1,470	+200%	+$8K	﹤0.01%	2819
2021 Q4	$5K	Hold	735	–	–	﹤0.01%	3032
2021 Q3	$11K	Buy	+735	New	+$12.2K	﹤0.01%	2903

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Ameritas Investment Partners's ABOS Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Acumen Pharmaceuticals (ABOS) in Q2 2025, closing a stake of 4,110 shares — an estimated $4.52K sold.

Ameritas Investment Partners first reported a position in ABOS in Q3 2021 and held it in 7 quarters. The position peaked at $11K in Q3 2021. 71 funds tracked by Wall St. Rank hold ABOS as of Q2 2025.

Ameritas Investment Partners reported no remaining Acumen Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 4,110 Acumen Pharmaceuticals shares in Q2 2025, an estimated $4.52K.
Ameritas Investment Partners first reported a position in Acumen Pharmaceuticals in Q3 2021 and held it in 7 quarters.
Ameritas Investment Partners's Acumen Pharmaceuticals position peaked at $11K in Q3 2021.
71 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.